Ginkgo Bioworks
| Ginkgo Bioworks | |
|---|---|
| Тип | бизнес, публичная компания и организация |
| Листинг на бирже | NYSE: DNA |
| Дата основания | 2009 |
| Основатели | Том Найт, Джейсон Келли, Решма Шетти, Бэрри Кантон, Остин Че |
| Расположение | Бостон, Массачусетс |
| Отрасль | биотехнология |
| Сайт | ginkgobioworks.com |
Ginkgo Bioworks — американская биотехнологическая компания, основанная в 2009 году учёными из Массачусетского технологического института и возглавляемая Джейсоном Келли. Компания специализируется на использовании генной инженерии для производства бактерий. В 2019 году компанию оценили в 4,2 миллиарда долларов. Она привлекла 290 миллионов долларов в сентябре и 350 миллионов долларов в октябре того же года.
История
16 декабря 2020 года стало известно, что Ginkgo Bioworks приобретёт главные активы платформы микробной инженерии Novogy.
11 мая 2021 года Gingko Bioworks объявила о планах выхода на биржу в результате слияния со SPAC Soaring Eagle при оценке в 17,5 миллиардов долларов.
14 мая 2021 года Ginkgo объявила, что новым тикером для NYSE будет DNA. Тикер ранее использовался активно Genentech, которая прекратила использовать тикер после приобретения Roche. Торги начались 17 сентября 2021 г. Компания Baillie Gifford стала крупнейшим акционером (15 %), купив 167,75 млн акций 31 марта 2022 г.
14 марта 2022 года стало известно, что Ginkgo Bioworks подписала соглашение о приобретении FGen AG, ведущей биоинженерной компании, и её собственной платформы для скрининга со сверхвысокой пропускной способностью.
6 июня 2022 года стало известно, что Ginkgo Bioworks приобрела активы у Bitome, интегрированной платформы мониторинга метаболитов.
25 июля 2022 года Ginkgo Bioworks согласилась приобрести Zymergen за 300 миллионов долларов в пределах сделки с полным пакетом акций.
4 октября 2022 года стало известно, что Ginkgo Bioworks приобретёт Adaptive Laboratory Evolution Company Altar.
4 октября 2022 года стало известно, что Ginkgo Bioworks приобретёт Circularis для расширения возможностей в области клеточной и генной терапии.
Примечания
- Susan Adams: Bayer And Ginkgo Bioworks, A Startup, Aim To Make Crops Produce Their Own Nitrogen Fertilizer — https://www.forbes.com/sites/susanadams/2017/09/14/new-venture-aims-to-make-crops-produce-their-own-nitrogen-fertilizer/
- https://www.forbes.com/sites/susanadams/2017/09/14/new-venture-aims-to-make-crops-produce-their-own-nitrogen-fertilizer/
- https://web.archive.org/web/20221010093004/https://www.forbes.com/sites/susanadams/2017/09/14/new-venture-aims-to-make-crops-produce-their-own-nitrogen-fertilizer/
- Robert Weisman Globe Staff, September 29, 2016, 8:00 a m Share on Facebook Share on TwitterView Comments: Ginkgo Bioworks opens production site for custom cells - The Boston Globe — https://www.bostonglobe.com/business/2016/09/29/ginkgo-bioworks-opens-production-site-for-custom-cells/NOkYPicm7tIusnQRhp0TYL/story.html
- https://www.bostonglobe.com/business/2016/09/29/ginkgo-bioworks-opens-production-site-for-custom-cells/NOkYPicm7tIusnQRhp0TYL/story.html
- https://web.archive.org/web/20221010093015/https://www.bostonglobe.com/business/2016/09/29/ginkgo-bioworks-opens-production-site-for-custom-cells/NOkYPicm7tIusnQRhp0TYL/story.html
- Ginkgo Bioworks raises $350 million fund for biotech spinouts — https://www.reuters.com/article/us-ginkgobio-fundraising-idUSKBN1WO1U9
- https://www.reuters.com/article/us-ginkgobio-fundraising-idUSKBN1WO1U9
- https://web.archive.org/web/20210427133901/https://www.reuters.com/article/us-ginkgobio-fundraising-idUSKBN1WO1U9
- Ginkgo Bioworks Acquires Biotechnology Startup Novogy's Microbial Engineering Platform — https://www.prnewswire.com/news-releases/ginkgo-bioworks-acquires-biotechnology-startup-novogys-microbial-engineering-platform-301194122.html
- https://www.prnewswire.com/news-releases/ginkgo-bioworks-acquires-biotechnology-startup-novogys-microbial-engineering-platform-301194122.html
- https://web.archive.org/web/20221008115911/https://www.prnewswire.com/news-releases/ginkgo-bioworks-acquires-biotechnology-startup-novogys-microbial-engineering-platform-301194122.html
- Biotech firm Ginkgo to merge with Harry Sloan-led SPAC in $17.5 bln deal — https://www.reuters.com/business/legal/biotech-firm-ginkgo-merge-with-harry-sloan-led-spac-175-bln-deal-2021-05-11/
- https://www.reuters.com/business/legal/biotech-firm-ginkgo-merge-with-harry-sloan-led-spac-175-bln-deal-2021-05-11/
- https://web.archive.org/web/20221010093014/https://www.reuters.com/business/legal/biotech-firm-ginkgo-merge-with-harry-sloan-led-spac-175-bln-deal-2021-05-11/
- Jason Kelly: Taking Ginkgo Public on NYSE:DNA — https://www.ginkgobioworks.com/2021/05/14/taking-ginkgo-public-on-nysedna/
- https://www.ginkgobioworks.com/2021/05/14/taking-ginkgo-public-on-nysedna/
- https://web.archive.org/web/20221010093008/https://www.ginkgobioworks.com/2021/05/14/taking-ginkgo-public-on-nysedna/
- Riley de León: Ginkgo Bioworks begins trading on the NYSE after completing SPAC merger — https://www.cnbc.com/2021/09/17/ginkgo-begins-trading-on-the-nyse-after-completing-spac-merger.html
- https://www.cnbc.com/2021/09/17/ginkgo-begins-trading-on-the-nyse-after-completing-spac-merger.html
- https://web.archive.org/web/20221010093005/https://www.cnbc.com/2021/09/17/ginkgo-begins-trading-on-the-nyse-after-completing-spac-merger.html
- Ginkgo Bioworks to Go Public with Over $1.6 Billion in Proceeds — https://www.businesswire.com/news/home/20210914005748/en/Ginkgo-Bioworks-to-Go-Public-with-Over-1.6-Billion-in-Proceeds
- https://www.businesswire.com/news/home/20210914005748/en/Ginkgo-Bioworks-to-Go-Public-with-Over-1.6-Billion-in-Proceeds
- https://web.archive.org/web/20221010093014/https://www.businesswire.com/news/home/20210914005748/en/Ginkgo-Bioworks-to-Go-Public-with-Over-1.6-Billion-in-Proceeds
- Eddie Pan: Baillie Gifford Just Bought Ginkgo Bioworks (DNA) Stock. Here's Why. — https://investorplace.com/2022/04/baillie-gifford-just-bought-ginkgo-bioworks-dna-stock-heres-why/
- https://investorplace.com/2022/04/baillie-gifford-just-bought-ginkgo-bioworks-dna-stock-heres-why/
- https://web.archive.org/web/20221010093015/https://investorplace.com/2022/04/baillie-gifford-just-bought-ginkgo-bioworks-dna-stock-heres-why/
- Ginkgo Bioworks Signs Definitive Agreement to Acquire FGen AG, a leading bioengineering company and its proprietary ultra-high-throughput screening platform — https://finance.yahoo.com/news/ginkgo-bioworks-signs-definitive-agreement-110000503.html
- https://finance.yahoo.com/news/ginkgo-bioworks-signs-definitive-agreement-110000503.html
- https://web.archive.org/web/20221008114334/https://finance.yahoo.com/news/ginkgo-bioworks-signs-definitive-agreement-110000503.html
- Ginkgo Bioworks Acquires Bitome, an Integrated Metabolite Monitoring Platform — https://www.prnewswire.com/news-releases/ginkgo-bioworks-acquires-bitome-an-integrated-metabolite-monitoring-platform-301561347.html
- https://www.prnewswire.com/news-releases/ginkgo-bioworks-acquires-bitome-an-integrated-metabolite-monitoring-platform-301561347.html
- https://web.archive.org/web/20221008115909/https://www.prnewswire.com/news-releases/ginkgo-bioworks-acquires-bitome-an-integrated-metabolite-monitoring-platform-301561347.html
- Derek Saul: Ginkgo Buys Embattled Biotech Firm Zymergen For Paltry $300 Million — https://www.forbes.com/sites/dereksaul/2022/07/25/ginkgo-buys-embattled-biotech-firm-zymergen-for-paltry-300-million/
- https://www.forbes.com/sites/dereksaul/2022/07/25/ginkgo-buys-embattled-biotech-firm-zymergen-for-paltry-300-million/
- https://web.archive.org/web/20221010093004/https://www.forbes.com/sites/dereksaul/2022/07/25/ginkgo-buys-embattled-biotech-firm-zymergen-for-paltry-300-million/
- Ginkgo Bioworks Acquires Adaptive Laboratory Evolution Company Altar — https://www.tipranks.com/news/press-releases/ginkgo-bioworks-acquires-adaptive-laboratory-evolution-company-altar
- https://www.tipranks.com/news/press-releases/ginkgo-bioworks-acquires-adaptive-laboratory-evolution-company-altar
- https://web.archive.org/web/20221007190049/https://www.tipranks.com/news/press-releases/ginkgo-bioworks-acquires-adaptive-laboratory-evolution-company-altar
- Julianna LeMieux PhD: Two Is Better Than One: Ginkgo Bioworks Acquires Altar and Circularis — https://www.genengnews.com/news/two-is-better-than-one-ginkgo-bioworks-acquires-altar-and-circularis/
- https://www.genengnews.com/news/two-is-better-than-one-ginkgo-bioworks-acquires-altar-and-circularis/
- https://web.archive.org/web/20221007115853/https://www.genengnews.com/news/two-is-better-than-one-ginkgo-bioworks-acquires-altar-and-circularis/
- Ginkgo Bioworks Acquires Circularis to Strengthen Capabilities in Cell and Gene Therapy — https://www.tipranks.com/news/press-releases/ginkgo-bioworks-acquires-circularis-to-strengthen-capabilities-in-cell-and-gene-therapy
- https://www.tipranks.com/news/press-releases/ginkgo-bioworks-acquires-circularis-to-strengthen-capabilities-in-cell-and-gene-therapy
- https://web.archive.org/web/20221008111059/https://www.tipranks.com/news/press-releases/ginkgo-bioworks-acquires-circularis-to-strengthen-capabilities-in-cell-and-gene-therapy